Skip to main content
300 Collins St Melbourne
hello@pivot.net
Login
Signup
Main navigation
About
Team
Contact
Research & Development
Innovation Engine
Therapeutic Focus
Development Strategy
Publications/Presentations
Pipeline
RMC-4630
Mutant RAS
SOS1
RMC-5552
Investors
Careers
Publications/Presentations
Publication / Presentation
June 22, 2020
SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway
Read more
Publication / Presentation
June 22, 2020
Dual inhibition of SHP2 and CDK4/6 leads to immunological memory and immune-mediated anti-tumor activity in a mouse syngeneic model of breast cancer
Read more
Publication / Presentation
June 22, 2020
Positioning a selective, bi-steric inhibitor of mTORC1 as a combination partner in RAS-driven cancers
Read more
Publication / Presentation
June 22, 2020
Discovery and development of allosteric inhibitors of SHP2
Read more
Publication / Presentation
April 29, 2020
Allosteric inhibition of SHP2 stimulates anti-tumor immunity by transforming the immunosuppressive environment
Read more
